Director, Early Phase Clinical Trials and Precision Therapeutics

Director, Early Phase Clinical Trials and Precision Therapeutics Apply now

to Director, Early Phase Clinical Trials and Precision Therapeutics

Job #JPF07744

Dean's Office / School of Medicine / UC Irvine

Application Window

Open date: October 12, 2022

Most recent review date: Monday, Jan 9, 2023 at 11:59pm (Pacific Time) Applications received after this date will be reviewed by the search committee if the position has not yet been filled.

Final date: Friday, May 12, 2023 at 11:59pm (Pacific Time) Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.

Position description

DIRECTOR, EARLY PHASE CLINICAL TRIALS & PRECISION THERAPEUTICS

The University of California, Irvine is seeking applicants for an Associate/Full Professor with tenure or Associate/Full Professor of Clinical X to serve as Director, Early Phase Clinical Trials & Precision Therapeutics. Incumbent will be responsible for the development and growth of UCI's early phase clinical trials portfolio for both oncology and non-oncology indications, across the UCI Chao Family Comprehensive Cancer Center's (CFCCC) Stern Center for Cancer Clinical Trials & Research (Stern Center), the UCI Center for Clinical Research (CCR), and the UCI Alpha Stem Cell Clinic (ASCC).

This position will report to the CFCCC Associate Director for Clinical Science, with dotted line reports to the CFCCC Medical Director of the Stern Center and the Associate Director for Translational Science; and the UCI School of Medicine Vice Dean for Clinical Research. The incumbent will maintain regular communication with School of Medicine leadership (Dean, Vice Deans, Institute for Clinical and Translational Science director, and clinical Chairs) and other key stakeholders (e.g., CFCCC Internal Advisory Board, External Advisory Board, CCR, and ASCC Advisory Boards).

Specific responsibilities include:

Develop and lead a coordinated Phase I program for cooperative group, industry, and institutional/investigator-initiated clinical trials across all therapeutic areas

Oversee, encourage, facilitate, and maximize enrollment on Phase I and Phase II trials across disease sites and various Departments. An important component will be developing a strong working relationship with the basic science and clinical department chairs and center directors.

Create, nurture and maintain critical contacts with industry partners

Work with institutional leadership across the three research entities (CFCCC Associate Director for Translational Science, CCR Medical Director, ASCC Medical Director) and the dean's office (Vice Deans for Research) to promote the translation of scientific discoveries toward the clinic through interactions with the various clinical research units at UCI

With the Department of Pathology and Laboratory Medicine, create and develop the infrastructure to support a regularly held molecular tumor board or equivalent

Ensure sufficient support levels for clinical/translational research including regulatory approval processes, biospecimen collection, and clinical research coordination; in short, all aspects of the clinical/translational research effort

Ensure an efficient infrastructure for formulation, launch, and completion of investigator-initiated early-phase clinical trials

Facilitate early phase clinical trials designed to maximize the development of cutting-edge therapies

Promote rapid progress by the Early Phase Clinical Trials Unit in cancer immunotherapy

Position the Early Phase Clinical Trials Unit to serve as a hub for precision medicine clinical trials by fostering seamless integration of oncology, genomics, computational biology, pathology, interventional and diagnostic radiology, and medical and surgical specialties

Develop innovative cellular therapies, collaborate in trial design, provide medical expertise, provide feedback on the scientific merit of the trials, and identify unmet medical needs and opportunities for pioneering new technologies

Ensure that early phase clinical research efforts reflect the health disparities and needs of the entirety of Orange County (e.g., underserved populations, including Latino and Asian populations)

Coordinate with the Disease-Oriented Teams across UCI Health, which function to facilitate the translation of basic science discoveries through the pipeline towards the clinic and to assess the scientific quality of proposed new protocols

Represent UCI and the CFCCC in this area for the University of California Cancer Consortium

Qualifications: • MD, MD/PhD degree or equivalent • Experience with phase 1 clinical trials in oncology • Strong leadership, coordination, team building, and management skills • Preferred Qualifications: subspecialty certification in an oncologic subspecialty including, but not limited to: Gynecologic Oncology, Hematology, Medical Oncology, Neurological Oncology or Surgical Oncology. Experience being involved in non-cancer therapeutics development in addition to the cancer experience is a plus

Applicants should complete an online application profile and upload the following application materials electronically to be considered for this position:

Cover Letter

Curriculum Vitae

Statement of Current and Future Research Plans

Statement of Teaching

Statement of Inclusive Excellence Activities - Statement addressing past and future planned contributions to inclusive excellence that will advance UCI's Commitment to Inclusive Excellence (For more information about the UCI Inclusive Excellence Activities Statement, please visit https: // inclusion.uci.edu/recruitment-resources/)

Contact information to request three reference letters

Criteria for the Ladder Rank Professor Series: Ladder-Rank Faculty will serve as Research Scholars and educators. They are expected to design and lead significant, thematic research with extramural support when that is needed. Teaching is required and may include clinical, classroom or lab teaching. The incumbent will have a major focus on innovative research of high significance as reflected in sustained, high-quality publications and peer-reviewed national funding as a principal investigator.

Criteria for the Clinical X Professor Series: The incumbent will be expected to conduct substantial and meaningful research; teach residents and medical students; and perform public and University service. Excellent teaching is an essential criterion for appointment in this series. Priority will be given to candidates with a proven track record of academic productivity, as demonstrated through high-impact publications, thematic-based research, and/or grant funding.

The home department appointment will be in whichever is most appropriate for the selected candidate.

Institutional Reference Check: The University of California is committed to creating and maintaining a community dedicated to the advancement, application, and transmission of knowledge and creative endeavors through academic excellence; where all individuals who participate in University programs and activities can work and learn together in a safe and secure environment, free of violence, harassment, discrimination, exploitation, or intimidation. In support of this commitment, and as a means to address all forms of academic misconduct, UC Irvine will conduct an institutional reference check on recruitment finalists of Senate Ladder-Rank Professor and Professor of Teaching series, at all ranks (i.e. assistant, associate, full), prior to extending a formal offer of appointment. Applications submitted via AP Recruit must include a signed copy of the Authorization to Release Information Form for consideration.

Qualifications

Basic qualifications (required at time of application)

• MD, MD/PhD degree or equivalent

Application Requirements

Document requirements

Curriculum Vitae - Your most recently updated C.V.

Cover Letter

Statement of Research

Teaching Statement - See our guidance for writing a reflective teaching statement.

Inclusive Excellence Activities Statement - Statement addressing how past and/or potential contributions to inclusive excellence will advance UCI's Commitment to Inclusive Excellence. See our guidance for writing an inclusive excellence activities statement.

Authorization to Release Information Form - A reference check will be completed only if you are made a tentative offer to a Professor or Professor of Teaching series, at any rank. Download, complete, sign, and upload the form: https: // ap.uci.edu/files/2020/07/AuthReleaseForm.pdf

Misc / Additional (Optional)

Reference requirements

3-5 required (contact information only)

Apply link: https: // recruit.ap.uci.edu/JPF07744

Campus Information

The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.

Apply now to Director, Early Phase Clinical Trials and Precision Therapeutics or

Log in to your portfolio

Need help? Contact the hiring department.

The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer. You have the right to an equal employment opportunity.

For more information about your rights, see the EEO is the Law Supplement

The University of California, Irvine is committed to providing reasonable accommodations to applicants with disabilities.

See our Jeanne Clery Disclosure of Campus Security Policy and Campus Crime Statistics Act Annual Security Reports